Clinical Trial Update: Nalmefene Implant in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating a nalmefene implant in healthy subjects for opioid use disorder is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Nalmefene implant (nalmefene)

Snippet

Sponsor: ReacX Pharmaceuticals, Inc. | Conditions: Opioid Abuse and Addiction | Phase 1 | Status: RECRUITING